Form 8-K - Current report:
SEC Accession No. 0001104659-22-063262
Filing Date
2022-05-20
Accepted
2022-05-20 13:09:23
Documents
13
Period of Report
2022-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2216126d1_8k.htm   iXBRL 8-K 42000
2 EXHIBIT 10.1 tm2216126d1_ex10-1.htm EX-10.1 162542
  Complete submission text file 0001104659-22-063262.txt   414637

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA glyc-20220518.xsd EX-101.SCH 3048
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE glyc-20220518_lab.xml EX-101.LAB 34476
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE glyc-20220518_pre.xml EX-101.PRE 22605
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2216126d1_8k_htm.xml XML 3482
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 22946627
SIC: 2834 Pharmaceutical Preparations